Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
第一作者:
Thomas,Heinicke
第一单位:
Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);德国(Germany);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);前瞻性研究(Prospective Studies);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1007/s00277-021-04565-1
PMID
34232360
发布时间
2024-01-31
- 浏览4
Annals of hematology
2387-2398页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



